Decreased prothrombin activity is associated with systemic pathological conditions such as coagulation factor deficiency [49], hepatic insufficiency [47], jaundice [50], albuminemia [51], etc., and multidimensional treatment is usually required. This evidence concerns the gene F2 and coagulation protein disease.